Influence of attenuation correction by integrated low-dose CT on somatostatin receptor SPECT

Nuclear Medicine Communications

Volumn 28, Issue 10, 2007, Pages 782-788

  Ruf, Juri ^a   Steffen, Ingo ^a   Mehl, Sebastian ^a   Rosner, Christian ^a   Denecke, Timm ^a   Pape, Ulrich Frank ^a   Plotkin, Michail ^a   Amthauer, Holger ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Artefacts; Attenuation correction; Neuroendocrine tumour; Single photon emission computed tomography; Somatostatin receptor scintigraphy

Indexed keywords

SOMATOSTATIN RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST; CORRELATION ANALYSIS; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; NEUROENDOCRINE TUMOR; RADIATION ATTENUATION; RADIATION DOSE; SCINTIGRAPHY; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL SIGNIFICANCE; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADULT; AGED; ARTIFACTS; FEMALE; HUMANS; IMAGE ENHANCEMENT; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; RADIATION DOSAGE; RADIOPHARMACEUTICALS; RECEPTORS, SOMATOSTATIN; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOMATOSTATIN; SUBTRACTION TECHNIQUE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34548324617     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e3282efa1a9     Document Type: Article

References (20)

1. 123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993; 20:716-731.
2. Forster GJ, Laumann C, Nickel O, Kann P, Rieker O, Bartenstein P. SPET/CT image co-registration in the abdomen with a simple and cost-effective tool. Eur J Nucl Med Mol Imaging 2003; 30:32-39.
3. Amthauer H, Ruf J, Bohmig M, Lopez-Hanninen E, Rohlfing T, Wernecke KD, et al. Diagnosis of neuroendocrine tumours by retrospective image fusion: is there a benefit? Eur J Nucl Med Mol Imaging 2004; 31:342-348.
4. Hillel PG, van Beek EJ, Taylor C, Lorenz E, Bax ND, Prakash V, Tindale WB. The clinical impact of a combined gamma camera/CT imaging system on somatostatin receptor imaging of neuroendocrine tumours. Clin Radiol 2006; 61:579-587.
5. 111In-pentetreotide in assessment of neuroendocrine tumours. Clin Endocrinol (Oxford) 2003; 59:565-573.
6. Amthauer H, Denecke T, Rohlfing T, Ruf J, Bohmig M, Gutberlet M, et al. Value of image fusion using single photon emission computed tomography with integrated low dose computed tomography in comparison with a retrospective voxel-based method in neuroendocrine tumours. Eur Radiol 2005; 15:1456-1462.
7. Tonge CM, Ellul G, Pandit M, Lawson RS, Shields RA, Arumugam P, Prescott MC. The value of registration correction in the attenuation correction of myocardial SPECT studies using low resolution computed tomography images. Nucl Med Commun 2006; 27:843-852.
8. Fricke H, Fricke E, Weise R, Kammeier A, Lindner O, Burchert W. A method to remove artifacts in attenuation-corrected myocardial perfusion SPECT Introduced by misalignment between emission scan and CT-derived attenuation maps. J Nucl Med 2004; 45:1619-1625.
9. Dondi M, Fagioli G, Salgarello M, Zoboli S, Nanni C, Cidda C. Myocardial SPECT: what do we gain from attenuation correction (and when)? Q J Nucl Med Mol Imaging 2004; 48:181-187.
10. Romer W, Fiedler E, Pavel M, Pfahlberg A, Hothorn T, Herzog H, et al. Attenuation correction of SPECT images based on separately performed CT: Effect on the measurement of regional uptake values. Nuklearmedizin 2005; 44:20-28.
11. Balon HR, Goldsmith SJ, Siegel BA, Silberstein EB, Krenning EP, Lang O, Donohoe KJ, for the Society of Nuclear Medicine. Procedure guideline for somatostatin receptor scintigraphy with (111)In-pentetreotide. J Nucl Med 2001; 42:1134-1138.
12. Pfannenberg AC, Eschmann SM, Horger M, Lamberts R, Vonthein R, Claussen CD, Bares R. Benefit of anatomical-functional image fusion in the diagnostic work-up of neuroendocrine neoplasms. Eur J Nucl Med Mol Imaging 2003; 30:835-843.
13. Ruf J, Seehofer D, Denecke T, Stelter L, Rayes N, Felix R, Amthauer H. Impact of image fusion and attenuation correction by SPECT-CT on the scintigraphic detection of parathyroid adenomas. Nuklearmedizin 2007; 46:15-21.
14. Cherry SR, Sorenson SA, Phelps M. Physics in Nuclear Medicine, 3rd edition. Philadelphia: Saunders; 2003.
15. Goerres GW, Burger C, Kamel E, Seifert B, Kaim AH, Buck A, et al. Respiration-induced attenuation artifact at PET/CT: technical considerations. Radiology 2003; 226:906-910.
16. Goerres GW, Ziegler SI, Burger C, Berthold T, Von Schulthess GK, Buck A. Artifacts at PET and PET/CT caused by metallic hip prosthetic material. Radiology 2003; 226:577-584.
17. Bocher M, Balan A, Krausz Y, Shrem Y, Lonn A, Wilk M, Chisin R. Gamma camera-mounted anatomical X-ray tomography: technology, system characteristics and first images. Eur J Nucl Med 2000; 27:619-627.
18. Nomayr A, Romer W, Strobel D, Bautz W, Kuwert T. Anatomical accuracy of hybrid SPECT/spiral CT in the lower spine. Nucl Med Commun 2006; 27:521-528.
19. Schulz V, Nickel I, Nomayr A, Vija AH, Hocke C, Hornegger J, et al. Effect of CT-based attenuation correction on uptake ratios in skeletal SPECT. Nuklearmedizin 2007; 46:36-42.
20. Ruf J, Lehmkuhl L, Bertram H, Sandrock D, Amthauer H, Humplik B, et al. Impact of SPECT and integrated low-dose CT after radioiodine therapy on the management of patients with thyroid carcinoma. Nucl Med Commun 2004; 25:1177-1182.